ENTR1 and metabolic disease: This finding demonstrated that SDCCAG3 serves as a beneficial factor for adipose tissue expansion and the regulation of metabolic homeostasis, positioning it as a potential therapeutic target for metabolic diseases in the context of nutrient surplus.